Pharma in 2014: Deals worth billions and fines worth millions
New Delhi: It's been a year of bitter medicine for Indian pharma companies with fines worth millions of dollars imposed by various foreign regulators, even as they stitched together deals worth billions of dollars, including the high…
Read More...
Read More...